Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Ann Clin Transl Neurol ; 9(10): 1673-1678, 2022 10.
Article in English | MEDLINE | ID: covidwho-2007086

ABSTRACT

Several cases of autoimmune encephalitis have been reported after ChAdOx1 nCoV-19 (AZD1222) vaccination. We encountered a male patient who presented with generalized tonic-clonic seizures, cognitive decline, and gait disturbance that occurred suddenly after the second dose of the ChAdOx1 nCoV-19 vaccine. Clinical presentation and magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) test results were compatible with limbic encephalitis. Synaptic autoantibody tests confirmed serum and CSF GABA B receptor antibodies were present. The patient was treated with immunotherapy with intravenous immunoglobulin and rituximab. This GABA-B receptor antibody encephalitis case occurred presumably due to transient autoantibody production following vaccine administration.


Subject(s)
COVID-19 , ChAdOx1 nCoV-19/adverse effects , Encephalitis , COVID-19/prevention & control , Encephalitis/chemically induced , Encephalomyelitis, Acute Disseminated , Humans , Immunoglobulins, Intravenous , Male , Receptors, GABA-B , Rituximab , Vaccination/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL